View in EDS

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.

Saved in:
Bibliographic Details
Title: Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.
Authors: Autio KA; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Antonarakis ES; University of Minnesota Medical School, Minneapolis, MN, USA., Mayer TM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Shevrin DH; NorthShore University HealthSystem, Evanston, IL, USA., Stein MN; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Vaishampayan UN; University of Michigan, Ann Arbor, MI, USA., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Slovin SF; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Heath EI; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Tagawa ST; Weill Cornell Medical College, New York, NY, USA., Rathkopf DE; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Milowsky MI; UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Harrison MR; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Balar AV; New York University, New York, NY, USA., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Paller CJ; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD, USA., Apollo A; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Danila DC; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Graff JN; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Nordquist L; Urology Cancer Center and GU Research Network, Omaha, NE, USA., Dayan Cohn ES; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tse K; Columbia University, New York, NY, USA., Schreiber NA; Convergent Therapeutics, New York, NY, USA., Heller G; Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.; Prostate Cancer Clinical Trials Consortium, New York, NY, USA.
Source: European urology open science [Eur Urol Open Sci] 2021 Nov 17; Vol. 34, pp. 70-78. Date of Electronic Publication: 2021 Nov 17 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34934969
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Autio+KA%22">Autio KA</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Antonarakis+ES%22">Antonarakis ES</searchLink>; University of Minnesota Medical School, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Mayer+TM%22">Mayer TM</searchLink>; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Shevrin+DH%22">Shevrin DH</searchLink>; NorthShore University HealthSystem, Evanston, IL, USA.<br /><searchLink fieldCode="AU" term="%22Stein+MN%22">Stein MN</searchLink>; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Vaishampayan+UN%22">Vaishampayan UN</searchLink>; University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Morris+MJ%22">Morris MJ</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Slovin+SF%22">Slovin SF</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Heath+EI%22">Heath EI</searchLink>; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Tagawa+ST%22">Tagawa ST</searchLink>; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rathkopf+DE%22">Rathkopf DE</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Milowsky+MI%22">Milowsky MI</searchLink>; UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Harrison+MR%22">Harrison MR</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Beer+TM%22">Beer TM</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Balar+AV%22">Balar AV</searchLink>; New York University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+AJ%22">Armstrong AJ</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22George+DJ%22">George DJ</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Paller+CJ%22">Paller CJ</searchLink>; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Apollo+A%22">Apollo A</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Danila+DC%22">Danila DC</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Graff+JN%22">Graff JN</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Nordquist+L%22">Nordquist L</searchLink>; Urology Cancer Center and GU Research Network, Omaha, NE, USA.<br /><searchLink fieldCode="AU" term="%22Dayan+Cohn+ES%22">Dayan Cohn ES</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tse+K%22">Tse K</searchLink>; Columbia University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Schreiber+NA%22">Schreiber NA</searchLink>; Convergent Therapeutics, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Heller+G%22">Heller G</searchLink>; Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Scher+HI%22">Scher HI</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.; Prostate Cancer Clinical Trials Consortium, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101771568%22">European urology open science</searchLink> [Eur Urol Open Sci] 2021 Nov 17; Vol. 34, pp. 70-78. <i>Date of Electronic Publication: </i>2021 Nov 17 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101771568 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-1683 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226661683%22">26661683 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Open Sci <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34934969
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euros.2021.09.015
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 70
    Titles:
      – TitleFull: Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Autio KA
      – PersonEntity:
          Name:
            NameFull: Antonarakis ES
      – PersonEntity:
          Name:
            NameFull: Mayer TM
      – PersonEntity:
          Name:
            NameFull: Shevrin DH
      – PersonEntity:
          Name:
            NameFull: Stein MN
      – PersonEntity:
          Name:
            NameFull: Vaishampayan UN
      – PersonEntity:
          Name:
            NameFull: Morris MJ
      – PersonEntity:
          Name:
            NameFull: Slovin SF
      – PersonEntity:
          Name:
            NameFull: Heath EI
      – PersonEntity:
          Name:
            NameFull: Tagawa ST
      – PersonEntity:
          Name:
            NameFull: Rathkopf DE
      – PersonEntity:
          Name:
            NameFull: Milowsky MI
      – PersonEntity:
          Name:
            NameFull: Harrison MR
      – PersonEntity:
          Name:
            NameFull: Beer TM
      – PersonEntity:
          Name:
            NameFull: Balar AV
      – PersonEntity:
          Name:
            NameFull: Armstrong AJ
      – PersonEntity:
          Name:
            NameFull: George DJ
      – PersonEntity:
          Name:
            NameFull: Paller CJ
      – PersonEntity:
          Name:
            NameFull: Apollo A
      – PersonEntity:
          Name:
            NameFull: Danila DC
      – PersonEntity:
          Name:
            NameFull: Graff JN
      – PersonEntity:
          Name:
            NameFull: Nordquist L
      – PersonEntity:
          Name:
            NameFull: Dayan Cohn ES
      – PersonEntity:
          Name:
            NameFull: Tse K
      – PersonEntity:
          Name:
            NameFull: Schreiber NA
      – PersonEntity:
          Name:
            NameFull: Heller G
      – PersonEntity:
          Name:
            NameFull: Scher HI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 11
              Text: 2021 Nov 17
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2666-1683
          Numbering:
            – Type: volume
              Value: 34
          Titles:
            – TitleFull: European urology open science
              Type: main
ResultId 1